UB Paderborn / Katalog / Suche / in CDI

1 – 15 von 15

Sortiert nach

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release

European journal of pharmacology, 2011-01, Vol.650 (1), p.220

2011

Volltextzugriff (PDF)

Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

European archives of psychiatry and clinical neuroscience, 2012-12, Vol.262 (8), p.657-666

2012

Volltextzugriff (PDF)

A robust model of Stimulus-Specific Adaptation validated on neuromorphic hardware

Scientific reports, 2021-09, Vol.11 (1), p.17904-17904, Article 17904

2021

Volltextzugriff (PDF)

Dopamine D 1 Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA

Basic & clinical pharmacology & toxicology, 2012-03, Vol.110 (3), p.283-289

2012

Volltextzugriff (PDF)

Dopamine D1 Receptor-Mediated Intracellular Responses in the Hypothalamus after Co-Administration of Caffeine with MDMA

Basic & clinical pharmacology & toxicology, 2012-03, Vol.110 (3), p.283-289

2012

Volltextzugriff (PDF)

Clenbuterol activates the central IL-1 system via the β2 -adrenoceptor without provoking inflammatory response related behaviours in rats

Brain, behavior, and immunity, 2016-08, Vol.56, p.114-129

2016

Volltextzugriff (PDF)

Clenbuterol activates the central IL-1 system via the beta 2-adrenoceptor without provoking inflammatory response related behaviours in rats

Brain, behavior, and immunity, 2016-08, Vol.56, p.114-129

2016

Volltextzugriff (PDF)

Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects

The world journal of biological psychiatry, 2013-09, Vol.14 (7), p.478-489

2013

Volltextzugriff (PDF)

The need for phosphoproteomic approaches in psychiatric research

Journal of psychiatric research, 2011-10, Vol.45 (10), p.1404-1406

2011

Volltextzugriff (PDF)

Proteomic technologies for biomarker studies in psychiatry: Advances and Needs

Biomarkers of Neurological and Psychiatric Disease, 2011, Vol.101, p.65-94

2011

Volltextzugriff (PDF)

Proteomic Technologies for Biomarker Studies in Psychiatry

International Review of Neurobiology, 2011, Vol.101, p.65-94

2011

Volltextzugriff (PDF)

Abnormalities in Metabolism and Hypothalamic–Pituitary–Adrenal Axis Function in Schizophrenia

Biomarkers of Neurological and Psychiatric Disease, 2011, Vol.101, p.145-168

2011

Volltextzugriff (PDF)

role for adenosine A₁ receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release

European journal of pharmacology, 2011, Vol.650 (1), p.220-228

2011

Volltextzugriff (PDF)

Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’)

Psychopharmacologia, 2010-07, Vol.211 (1), p.15-25

2010

Volltextzugriff (PDF)

A role for adenosine A 1 receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release

European journal of pharmacology, 2011, Vol.650 (1), p.220-228

2011

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(13)
Buchkapitel
(2)

Sprache

Englisch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release

Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

A robust model of Stimulus-Specific Adaptation validated on neuromorphic hardware

Dopamine D 1 Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA

Dopamine D1 Receptor-Mediated Intracellular Responses in the Hypothalamus after Co-Administration of Caffeine with MDMA

Clenbuterol activates the central IL-1 system via the β2 -adrenoceptor without provoking inflammatory response related behaviours in rats

Clenbuterol activates the central IL-1 system via the beta 2-adrenoceptor without provoking inflammatory response related behaviours in rats

Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects

The need for phosphoproteomic approaches in psychiatric research

Proteomic technologies for biomarker studies in psychiatry: Advances and Needs

Proteomic Technologies for Biomarker Studies in Psychiatry

Abnormalities in Metabolism and Hypothalamic–Pituitary–Adrenal Axis Function in Schizophrenia

role for adenosine A₁ receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release

Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioural responses to MDMA (‘ecstasy’)

A role for adenosine A 1 receptor blockade in the ability of caffeine to promote MDMA “Ecstasy”-induced striatal dopamine release

Suchergebnisse filtern